Réaction #502137

ord-17816114ba774dbab023c742b6a0f60a

Conditions de réaction

Conditions détaillées
See reaction.notes.procedure_details.

Traitement

  1. 1
    AutreAfter removal of the volatile constituents in vacuo
  2. 2
    Autrethe residue is purified by preparative HPLC

Mode opératoire

100 mg (0.34 mmol) of 2-(3,4-dichlorobenzyl)-4-(methylsulphanyl)-6-oxo-1,6-dihydropyrimidine-5-carbonitrile are stirred with 261 mg (3.07 mmol) of piperidine at 85° C. for 16 h. After removal of the volatile constituents in vacuo, the residue is purified by preparative HPLC. 42 mg (38% of theory) of the title compound are obtained.

Source

DOI: 10.6084/m9.figshare.5104873.v1Brevet: US08088769B2uspto-grants-2012_01